Skip to main content
Clinical Trials/IRCT2015090323621N3
IRCT2015090323621N3
Completed
Phase 2

Comparison of induction and ovulation with Clomiphene plus Letrozole versus Clomiphene plus HMG in Clomiphene resistant polycystic ovary syndrome

Vice Chancellor for research of Iran Univercity of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Female infertility.
Sponsor
Vice Chancellor for research of Iran Univercity of Medical Sciences
Enrollment
200
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice Chancellor for research of Iran Univercity of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Women with history of infertility more over than one year and diagnosis of PCOS based on the revised 2003 consensus on diagnostic criteria; By clomiphene resistance that meant failure of ovulation after 100\-150 mg CC for 5 days for 2\-3 cycles and then resistant to letrozole 2\.5 mg daily for 5 days for 2 cycles. Exclusion criteria: Women older than 40 years or younger than 20; fallopian tubes abnormality proved by hysterosalpingography; abnormal semen analysis for their partners according to the modified criteria of the World Health Organization; endocrine problem like hyper or hypo thyroidism, hyperprolactinemia; abnormal karyotype.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials